(Q41547576)

3 October 2017

1 reference

title

Glycosphingolipids as potential diagnostic markers and/or antigens in neurological disorders (English)

1 reference

3 October 2017

Fredman P

1

1 reference

PubMed ID

9239764

3 October 2017

Lekman A

series ordinal

2

1 reference

3 October 2017

1 August 1997

1 reference

3 October 2017

13

1 reference

inferred from page(s)

published in

Neurochemical Research

1 reference

3 October 2017

22

1 reference

3 October 2017

8

1 reference

3 October 2017

1071-1083

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1022495430583

3 October 2017

0 references

cites work

Highly sensitive analysis of gangliosides in human cerebrospinal fluid with neurological diseases

1 reference

12 December 2020

N-acetylglucosaminyltransferase regulates the expression of neolactoglycolipids including sulfoglucuronylglycolipids in the developing nervous system.

1 reference

12 December 2020

Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin

1 reference

12 December 2020

Antiganglioside antibodies in the CSF of patients with motor neuron diseases and Guillain-Barré syndrome

1 reference

12 December 2020

Monosialoganglioside (GM1) immunofluorescence in rat spinal roots studied with a monoclonal antibody

1 reference

12 December 2020

Autoimmune ataxic neuropathies (sensory ganglionopathies): are glycolipids the responsible autoantigens?

1 reference

12 December 2020

Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome

1 reference

12 December 2020

Gangliosides and allied glycosphingolipids in human peripheral nerve and spinal cord

1 reference

12 December 2020

Gangliosides in serum immune complexes from tumor-bearing patients

1 reference

12 December 2020

Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside

1 reference

12 December 2020

Human brain gangliosides: developmental changes from early fetal stage to advanced age.

1 reference

12 December 2020

Antibodies against GM1 ganglioside affect K+ and Na+ currents in isolated rat myelinated nerve fibers

1 reference

12 December 2020

Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values

1 reference

12 December 2020

Structure of sulfated glucuronyl glycolipids in the nervous system reacting with HNK-1 antibody and some IgM paraproteins in neuropathy.

1 reference

12 December 2020

Sulphatide and sulphatide antibodies in insulin-dependent diabetes mellitus

1 reference

12 December 2020

The clinical and diagnostic role of anti-GM1 antibody testing

1 reference

12 December 2020

Sulfatide as a biochemical marker in cerebrospinal fluid of patients with vascular dementia

1 reference

12 December 2020

Precise characterization and quantification of infantile spasms

1 reference

12 December 2020

Gangliosides of human cerebrospinal fluid in various neurologic diseases.

1 reference

12 December 2020

In vivo growth conditions suppress the expression of ganglioside GM2 and favour that of lacto series gangliosides in the human glioma D-54MG cell line

1 reference

12 December 2020

Occurrence of GD3 ganglioside in reactive astrocytes--an immunocytochemical study in the rat brain.

1 reference

12 December 2020

Tracing glial cell lineages in the mammalian forebrain

1 reference

12 December 2020

Ganglioside antibodies: a lack of diagnostic specificity and clinical utility?

1 reference

12 December 2020

Low levels of CSF gangliotetraose-series gangliosides in West syndrome: implication of brain maturation disturbance.

1 reference

12 December 2020

Measurement and significance of antibodies against GM1 ganglioside. Report of a workshop, 18 April 1989, Chicago, IL, U.S.A.

1 reference

12 December 2020

Guillain-Barré syndrome and Campylobacter jejuni: a serological study

1 reference

12 December 2020

THE DISTRIBUTION OF LIPIDS IN THE HUMAN NERVOUS SYSTEM. I. ANALYTICAL PROCEDURE. LIPIDS OF FOETAL AND NEWBORN BRAIN

1 reference

12 December 2020

Gangliosides in cerebrospinal fluid in children with autism spectrum disorders.

1 reference

12 December 2020

IgM in a human neuropathy related to paraproteinemia binds to a carbohydrate determinant in the myelin-associated glycoprotein and to a ganglioside

1 reference

12 December 2020

Sensitive enzyme-immunostaining and densitometric determination of ganglio-series gangliosides on thin-layer plate: pmol detection of gangliosides in cerebrospinal fluid

1 reference

12 December 2020

Gangliosides in the nervous system during development and regeneration

1 reference

12 December 2020

Developmental profiles of gangliosides in human and rat brain

1 reference

12 December 2020

A comparative trial of anti-glycoconjugate antibody assays: IgM antibodies to GM1

1 reference

12 December 2020

Gangliosides and sulfatide in cerebrospinal fluid in leukoaraiosis.

1 reference

12 December 2020

Cell surface shedding--the phenomenon and its possible significance

1 reference

12 December 2020

Antibody detection in Guillain-Barré syndrome

1 reference

12 December 2020

Normal developmental profiles of CSF gangliotetraose-series gangliosides from neonatal period to adolescence.

1 reference

12 December 2020

Intrathecal synthesis of anti-sulfatide IgG is associated with peripheral nerve disease in acquired immunodeficiency syndrome

1 reference

12 December 2020

The sensitivity and specificity of anti-GM1 antibody testing

1 reference

12 December 2020

Determination of gangliosides and sulfatide in human cerebrospinal fluid with a microimmunoaffinity technique

1 reference

12 December 2020

Gangliosides associated with primary brain tumors and their expression in cell lines established from these tumors.

1 reference

12 December 2020

Antiganglioside antibodies do not necessarily play a role in multifocal motor neuropathy

1 reference

12 December 2020

Preliminary observations of gangliosides of normal and multiple sclerosis cerebrospinal fluid

1 reference

12 December 2020

Ganglioside GM1 overcomes serum inhibition of neuritic outgrowth

1 reference

12 December 2020

Elevated cerebrospinal fluid sulfatide concentrations as a sign of increased metabolic turnover of myelin in HIV type I infection.

1 reference

12 December 2020

Invited review: motor neuropathies, motor neuron disorders, and antiglycolipid antibodies

1 reference

12 December 2020

Gangliosides in children with autism.

1 reference

12 December 2020

Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies

1 reference

12 December 2020

Myelin-Associated Glycoprotein in Development and Disease

1 reference

12 December 2020

In vivo demyelinating activity of sera from patients with Guillain-Barré syndrome

1 reference

12 December 2020

Immunological investigation.

1 reference

12 December 2020

Differential effects of prednisone and cyclophosphamide on autoantibodies in human neuromuscular disorders

1 reference

12 December 2020

Accumulation of ganglioside Gm2 in cerebrospinal fluid of a patient with the variant AB of infantile Gm2 gangliosidosis

1 reference

12 December 2020

Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability.

1 reference

12 December 2020

Epilepsies of infancy and childhood

1 reference

12 December 2020

The spectrum of neurologic disease associated with anti-GM1 antibodies

1 reference

12 December 2020

Sorting of newly synthesized galactosphingolipids to the two surface domains of epithelial cells

1 reference

12 December 2020

Ganglioside localization on myelinated nerve fibres by cholera toxin binding

1 reference

12 December 2020

Gangliosides in normal human serum. Concentration, pattern and transport by lipoproteins

1 reference

12 December 2020

Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis

1 reference

12 December 2020

Plasmapheresis alleviates neuropathy accompanying IgM anti-myelin-associated glycoprotein paraproteinemia

1 reference

12 December 2020

Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy

1 reference

12 December 2020

The Biochemical Basis of Gangliosidoses

1 reference

12 December 2020

Functional role of glycosphingolipids in cell recognition and signaling

1 reference

12 December 2020

Rostrocaudal expression of antibody HNK-1-reactive glycolipids in mouse cerebellum: relationship to developmental compartments and leaner mutation.

1 reference

12 December 2020

Differential distribution of major gangliosides in rat central nervous system detected by specific monoclonal antibodies.

1 reference

12 December 2020

Gangliosides and sulphatide in human cerebrospinal fluid: quantitation with immunoaffinity techniques

1 reference

12 December 2020

Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti-MAG IgM M-protein

1 reference

12 December 2020

Factors affecting the fine specificity and sensitivity of serum antiganglioside antibodies in ELISA.

1 reference

12 December 2020

Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features

1 reference

12 December 2020

Strongly GD3+ cells in the developing and adult rat cerebellum belong to the microglial lineage rather than to the oligodendrocyte lineage

1 reference

12 December 2020

Pattern of nervous tissue immunostaining by human anti-glycolipid antibodies

1 reference

12 December 2020

Presence of sulphatide (3'-sulphogalactosylceramide) in pericytes in the choroid layer of the eye: sharing of this glycolipid autoantigen with islets of Langerhans

1 reference

12 December 2020

Inflammatory neuropathies

1 reference

12 December 2020

The role(s) of gangliosides in neural differentiation and repair: a perspective

1 reference

12 December 2020

A new procedure for determining ganglioside GD3 a potential glial cell activation marker in cerebrospinal fluid

1 reference

12 December 2020

Alteration of gangliosides in plasma and red cells of humans bearing melanoma tumors

1 reference

12 December 2020

Glycoconjugates in autoimmunity

1 reference

12 December 2020

Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelin-associated glycoprotein

1 reference

12 December 2020

Effect of development on the gangliosides of human brain.

1 reference

12 December 2020

Peripheral neuropathy associated with monoclonal IgM antibody to glycolipids with a terminal glucuronyl-3-sulfate epitope.

1 reference

12 December 2020

A characteristic ganglioside antibody pattern in the CSF of patients with amyotrophic lateral sclerosis

1 reference

12 December 2020

Multifocal motor neuropathy: response to human immune globulin

1 reference

12 December 2020

Antiglycolipid antibodies in peripheral neuropathy: fact or fiction?

1 reference

12 December 2020

Failure of anti-GM1 IgG or IgM to induce conduction block following intraneural transfer

1 reference

12 December 2020

Increased cerebrospinal fluid ganglioside GM1 concentrations indicating neuronal involvement in all stages of HIV-1 infection.

1 reference

12 December 2020

AB variant GM2 gangliosidosis: cerebrospinal fluid and neuropathologic characteristics.

1 reference

12 December 2020

GD3 ganglioside is a glycolipid characteristic of immature neuroectodermal cells.

1 reference

12 December 2020

Gangliosides in cerebrospinal fluid in 'probable Alzheimer's disease'.

1 reference

12 December 2020

Ultrastructural localization of cell membrane G M1 ganglioside by cholera toxin

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1022495430583

1 reference

PubMed ID

9239764

Dimensions Publication ID

3 October 2017

0 references

1 reference

PubMed ID

9239764